Click for best price
Porcine Vaccines Market Size, Share 2024
| Market size in 2023 |
US$ 1268.6 million
|
Forecast Market size by 2030 |
US$ 2019 million
|
| Growth Rate |
CAGR of 6.8% |
Number of Pages |
135 Pages |
This research report provides a comprehensive analysis of the Porcine Vaccines market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Porcine Vaccines market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Porcine Vaccines, challenges faced by the industry, and potential opportunities for market players.
The global Porcine Vaccines market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Porcine Vaccines market presents opportunities for various stakeholders, including Government Tender, Market Sales. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Porcine Vaccines market. Additionally, the growing consumer demand present avenues for market expansion.
The global Porcine Vaccines market was valued at US$ 1268.6 million in 2023 and is projected to reach US$ 2019 million by 2030, at a CAGR of 6.8% during the forecast period.
The porcine vaccines market is experiencing steady growth due to the increasing demand for improved animal health and the rising prevalence of swine diseases. Porcine vaccines play a crucial role in preventing and controlling various viral, bacterial, and parasitic diseases in pigs. The market is driven by factors such as the growth of the swine industry, rising awareness about the benefits of vaccination, and the implementation of stringent animal health regulations. Additionally, advancements in vaccine technology, such as the development of more efficacious and safer vaccines, are fueling market growth. However, challenges such as high costs associated with vaccine development and production, and the presence of counterfeit vaccines in some regions, may hamper market growth. With the continuous focus on disease prevention and the need to ensure a healthy pig population, the porcine vaccines market is expected to witness sustained growth in the coming years.
Key Features:
The research report on the Porcine Vaccines market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Porcine Vaccines market.
Market Overview: The report provides a comprehensive overview of the Porcine Vaccines market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., CSF Vaccines, FMD Vaccines), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Porcine Vaccines market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Porcine Vaccines market's trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Porcine Vaccines market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Porcine Vaccines market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Porcine Vaccines market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Porcine Vaccines market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Porcine Vaccines, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Porcine Vaccines market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
- Porcine Vaccines market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- CSF Vaccines
- FMD Vaccines
- Porcine Circovirus Vaccines
- PRRS Vaccines
- Other
Market segment by Application
- Government Tender
- Market Sales
Global Porcine Vaccines Market Segment Percentages, By Region and Country, 2023 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Major players covered
- Merck
- Boehringer Ingelheim
- Jinyu Bio-Technology
- CAHIC
- Tecon
- Zoetis
- Ceva
- Hile Bio
- Chopper Biology
- WINSUN
- Hipra
- Ringpu Biology
- DHN
- CAVAC
- Virbac
- HVRI
- Bioveta
Outline of Major Chapters:
Chapter 1: Introduces the definition of Porcine Vaccines, market overview.
Chapter 2: Global Porcine Vaccines market size in revenue and volume.
Chapter 3: Detailed analysis of Porcine Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Porcine Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Porcine Vaccines capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Porcine Vaccines Market, Global Outlook and Forecast 2024-2030 |
| Market size in 2023 |
US$ 1268.6 million
|
| Forecast Market size by 2030 |
US$ 2019 million
|
| Growth Rate |
CAGR of 6.8% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
135 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Porcine Vaccines Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Porcine Vaccines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Porcine Vaccines Overall Market Size
2.1 Global Porcine Vaccines Market Size: 2023 VS 2030
2.2 Global Porcine Vaccines Revenue, Prospects & Forecasts: 2019-2030
2.3 Global Porcine Vaccines Sales: 2019-2030
3 Company Landscape
3.1 Top Porcine Vaccines Players in Global Market
3.2 Top Global Porcine Vaccines Companies Ranked by Revenue
3.3 Global Porcine Vaccines Revenue by Companies
3.4 Global Porcine Vaccines Sales by Companies
3.5 Global Porcine Vaccines Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Porcine Vaccines Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers Porcine Vaccines Product Type
3.8 Tier 1, Tier 2 and Tier 3 Porcine Vaccines Players in Global Market
3.8.1 List of Global Tier 1 Porcine Vaccines Companies
3.8.2 List of Global Tier 2 and Tier 3 Porcine Vaccines Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Porcine Vaccines Market Size Markets, 2023 & 2030
4.1.2 CSF Vaccines
4.1.3 FMD Vaccines
4.1.4 Porcine Circovirus Vaccines
4.1.5 PRRS Vaccines
4.1.6 Other
4.2 By Type - Global Porcine Vaccines Revenue & Forecasts
4.2.1 By Type - Global Porcine Vaccines Revenue, 2019-2024
4.2.2 By Type - Global Porcine Vaccines Revenue, 2025-2030
4.2.3 By Type - Global Porcine Vaccines Revenue Market Share, 2019-2030
4.3 By Type - Global Porcine Vaccines Sales & Forecasts
4.3.1 By Type - Global Porcine Vaccines Sales, 2019-2024
4.3.2 By Type - Global Porcine Vaccines Sales, 2025-2030
4.3.3 By Type - Global Porcine Vaccines Sales Market Share, 2019-2030
4.4 By Type - Global Porcine Vaccines Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Porcine Vaccines Market Size, 2023 & 2030
5.1.2 Government Tender
5.1.3 Market Sales
5.2 By Application - Global Porcine Vaccines Revenue & Forecasts
5.2.1 By Application - Global Porcine Vaccines Revenue, 2019-2024
5.2.2 By Application - Global Porcine Vaccines Revenue, 2025-2030
5.2.3 By Application - Global Porcine Vaccines Revenue Market Share, 2019-2030
5.3 By Application - Global Porcine Vaccines Sales & Forecasts
5.3.1 By Application - Global Porcine Vaccines Sales, 2019-2024
5.3.2 By Application - Global Porcine Vaccines Sales, 2025-2030
5.3.3 By Application - Global Porcine Vaccines Sales Market Share, 2019-2030
5.4 By Application - Global Porcine Vaccines Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global Porcine Vaccines Market Size, 2023 & 2030
6.2 By Region - Global Porcine Vaccines Revenue & Forecasts
6.2.1 By Region - Global Porcine Vaccines Revenue, 2019-2024
6.2.2 By Region - Global Porcine Vaccines Revenue, 2025-2030
6.2.3 By Region - Global Porcine Vaccines Revenue Market Share, 2019-2030
6.3 By Region - Global Porcine Vaccines Sales & Forecasts
6.3.1 By Region - Global Porcine Vaccines Sales, 2019-2024
6.3.2 By Region - Global Porcine Vaccines Sales, 2025-2030
6.3.3 By Region - Global Porcine Vaccines Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America Porcine Vaccines Revenue, 2019-2030
6.4.2 By Country - North America Porcine Vaccines Sales, 2019-2030
6.4.3 US Porcine Vaccines Market Size, 2019-2030
6.4.4 Canada Porcine Vaccines Market Size, 2019-2030
6.4.5 Mexico Porcine Vaccines Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe Porcine Vaccines Revenue, 2019-2030
6.5.2 By Country - Europe Porcine Vaccines Sales, 2019-2030
6.5.3 Germany Porcine Vaccines Market Size, 2019-2030
6.5.4 France Porcine Vaccines Market Size, 2019-2030
6.5.5 U.K. Porcine Vaccines Market Size, 2019-2030
6.5.6 Italy Porcine Vaccines Market Size, 2019-2030
6.5.7 Russia Porcine Vaccines Market Size, 2019-2030
6.5.8 Nordic Countries Porcine Vaccines Market Size, 2019-2030
6.5.9 Benelux Porcine Vaccines Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia Porcine Vaccines Revenue, 2019-2030
6.6.2 By Region - Asia Porcine Vaccines Sales, 2019-2030
6.6.3 China Porcine Vaccines Market Size, 2019-2030
6.6.4 Japan Porcine Vaccines Market Size, 2019-2030
6.6.5 South Korea Porcine Vaccines Market Size, 2019-2030
6.6.6 Southeast Asia Porcine Vaccines Market Size, 2019-2030
6.6.7 India Porcine Vaccines Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America Porcine Vaccines Revenue, 2019-2030
6.7.2 By Country - South America Porcine Vaccines Sales, 2019-2030
6.7.3 Brazil Porcine Vaccines Market Size, 2019-2030
6.7.4 Argentina Porcine Vaccines Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Porcine Vaccines Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa Porcine Vaccines Sales, 2019-2030
6.8.3 Turkey Porcine Vaccines Market Size, 2019-2030
6.8.4 Israel Porcine Vaccines Market Size, 2019-2030
6.8.5 Saudi Arabia Porcine Vaccines Market Size, 2019-2030
6.8.6 UAE Porcine Vaccines Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 Merck
7.1.1 Merck Company Summary
7.1.2 Merck Business Overview
7.1.3 Merck Porcine Vaccines Major Product Offerings
7.1.4 Merck Porcine Vaccines Sales and Revenue in Global (2019-2024)
7.1.5 Merck Key News & Latest Developments
7.2 Boehringer Ingelheim
7.2.1 Boehringer Ingelheim Company Summary
7.2.2 Boehringer Ingelheim Business Overview
7.2.3 Boehringer Ingelheim Porcine Vaccines Major Product Offerings
7.2.4 Boehringer Ingelheim Porcine Vaccines Sales and Revenue in Global (2019-2024)
7.2.5 Boehringer Ingelheim Key News & Latest Developments
7.3 Jinyu Bio-Technology
7.3.1 Jinyu Bio-Technology Company Summary
7.3.2 Jinyu Bio-Technology Business Overview
7.3.3 Jinyu Bio-Technology Porcine Vaccines Major Product Offerings
7.3.4 Jinyu Bio-Technology Porcine Vaccines Sales and Revenue in Global (2019-2024)
7.3.5 Jinyu Bio-Technology Key News & Latest Developments
7.4 CAHIC
7.4.1 CAHIC Company Summary
7.4.2 CAHIC Business Overview
7.4.3 CAHIC Porcine Vaccines Major Product Offerings
7.4.4 CAHIC Porcine Vaccines Sales and Revenue in Global (2019-2024)
7.4.5 CAHIC Key News & Latest Developments
7.5 Tecon
7.5.1 Tecon Company Summary
7.5.2 Tecon Business Overview
7.5.3 Tecon Porcine Vaccines Major Product Offerings
7.5.4 Tecon Porcine Vaccines Sales and Revenue in Global (2019-2024)
7.5.5 Tecon Key News & Latest Developments
7.6 Zoetis
7.6.1 Zoetis Company Summary
7.6.2 Zoetis Business Overview
7.6.3 Zoetis Porcine Vaccines Major Product Offerings
7.6.4 Zoetis Porcine Vaccines Sales and Revenue in Global (2019-2024)
7.6.5 Zoetis Key News & Latest Developments
7.7 Ceva
7.7.1 Ceva Company Summary
7.7.2 Ceva Business Overview
7.7.3 Ceva Porcine Vaccines Major Product Offerings
7.7.4 Ceva Porcine Vaccines Sales and Revenue in Global (2019-2024)
7.7.5 Ceva Key News & Latest Developments
7.8 Hile Bio
7.8.1 Hile Bio Company Summary
7.8.2 Hile Bio Business Overview
7.8.3 Hile Bio Porcine Vaccines Major Product Offerings
7.8.4 Hile Bio Porcine Vaccines Sales and Revenue in Global (2019-2024)
7.8.5 Hile Bio Key News & Latest Developments
7.9 Chopper Biology
7.9.1 Chopper Biology Company Summary
7.9.2 Chopper Biology Business Overview
7.9.3 Chopper Biology Porcine Vaccines Major Product Offerings
7.9.4 Chopper Biology Porcine Vaccines Sales and Revenue in Global (2019-2024)
7.9.5 Chopper Biology Key News & Latest Developments
7.10 WINSUN
7.10.1 WINSUN Company Summary
7.10.2 WINSUN Business Overview
7.10.3 WINSUN Porcine Vaccines Major Product Offerings
7.10.4 WINSUN Porcine Vaccines Sales and Revenue in Global (2019-2024)
7.10.5 WINSUN Key News & Latest Developments
7.11 Hipra
7.11.1 Hipra Company Summary
7.11.2 Hipra Business Overview
7.11.3 Hipra Porcine Vaccines Major Product Offerings
7.11.4 Hipra Porcine Vaccines Sales and Revenue in Global (2019-2024)
7.11.5 Hipra Key News & Latest Developments
7.12 Ringpu Biology
7.12.1 Ringpu Biology Company Summary
7.12.2 Ringpu Biology Business Overview
7.12.3 Ringpu Biology Porcine Vaccines Major Product Offerings
7.12.4 Ringpu Biology Porcine Vaccines Sales and Revenue in Global (2019-2024)
7.12.5 Ringpu Biology Key News & Latest Developments
7.13 DHN
7.13.1 DHN Company Summary
7.13.2 DHN Business Overview
7.13.3 DHN Porcine Vaccines Major Product Offerings
7.13.4 DHN Porcine Vaccines Sales and Revenue in Global (2019-2024)
7.13.5 DHN Key News & Latest Developments
7.14 CAVAC
7.14.1 CAVAC Company Summary
7.14.2 CAVAC Business Overview
7.14.3 CAVAC Porcine Vaccines Major Product Offerings
7.14.4 CAVAC Porcine Vaccines Sales and Revenue in Global (2019-2024)
7.14.5 CAVAC Key News & Latest Developments
7.15 Virbac
7.15.1 Virbac Company Summary
7.15.2 Virbac Business Overview
7.15.3 Virbac Porcine Vaccines Major Product Offerings
7.15.4 Virbac Porcine Vaccines Sales and Revenue in Global (2019-2024)
7.15.5 Virbac Key News & Latest Developments
7.16 HVRI
7.16.1 HVRI Company Summary
7.16.2 HVRI Business Overview
7.16.3 HVRI Porcine Vaccines Major Product Offerings
7.16.4 HVRI Porcine Vaccines Sales and Revenue in Global (2019-2024)
7.16.5 HVRI Key News & Latest Developments
7.17 Bioveta
7.17.1 Bioveta Company Summary
7.17.2 Bioveta Business Overview
7.17.3 Bioveta Porcine Vaccines Major Product Offerings
7.17.4 Bioveta Porcine Vaccines Sales and Revenue in Global (2019-2024)
7.17.5 Bioveta Key News & Latest Developments
8 Global Porcine Vaccines Production Capacity, Analysis
8.1 Global Porcine Vaccines Production Capacity, 2019-2030
8.2 Porcine Vaccines Production Capacity of Key Manufacturers in Global Market
8.3 Global Porcine Vaccines Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Porcine Vaccines Supply Chain Analysis
10.1 Porcine Vaccines Industry Value Chain
10.2 Porcine Vaccines Upstream Market
10.3 Porcine Vaccines Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Porcine Vaccines Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Porcine Vaccines in Global Market
Table 2. Top Porcine Vaccines Players in Global Market, Ranking by Revenue (2023)
Table 3. Global Porcine Vaccines Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global Porcine Vaccines Revenue Share by Companies, 2019-2024
Table 5. Global Porcine Vaccines Sales by Companies, (M Units), 2019-2024
Table 6. Global Porcine Vaccines Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers Porcine Vaccines Price (2019-2024) & (USD/K Unit)
Table 8. Global Manufacturers Porcine Vaccines Product Type
Table 9. List of Global Tier 1 Porcine Vaccines Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Porcine Vaccines Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Porcine Vaccines Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Global Porcine Vaccines Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global Porcine Vaccines Revenue (US$, Mn), 2025-2030
Table 14. By Type - Global Porcine Vaccines Sales (M Units), 2019-2024
Table 15. By Type - Global Porcine Vaccines Sales (M Units), 2025-2030
Table 16. By Application ? Global Porcine Vaccines Revenue, (US$, Mn), 2023 & 2030
Table 17. By Application - Global Porcine Vaccines Revenue (US$, Mn), 2019-2024
Table 18. By Application - Global Porcine Vaccines Revenue (US$, Mn), 2025-2030
Table 19. By Application - Global Porcine Vaccines Sales (M Units), 2019-2024
Table 20. By Application - Global Porcine Vaccines Sales (M Units), 2025-2030
Table 21. By Region ? Global Porcine Vaccines Revenue, (US$, Mn), 2023 VS 2030
Table 22. By Region - Global Porcine Vaccines Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global Porcine Vaccines Revenue (US$, Mn), 2025-2030
Table 24. By Region - Global Porcine Vaccines Sales (M Units), 2019-2024
Table 25. By Region - Global Porcine Vaccines Sales (M Units), 2025-2030
Table 26. By Country - North America Porcine Vaccines Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America Porcine Vaccines Revenue, (US$, Mn), 2025-2030
Table 28. By Country - North America Porcine Vaccines Sales, (M Units), 2019-2024
Table 29. By Country - North America Porcine Vaccines Sales, (M Units), 2025-2030
Table 30. By Country - Europe Porcine Vaccines Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe Porcine Vaccines Revenue, (US$, Mn), 2025-2030
Table 32. By Country - Europe Porcine Vaccines Sales, (M Units), 2019-2024
Table 33. By Country - Europe Porcine Vaccines Sales, (M Units), 2025-2030
Table 34. By Region - Asia Porcine Vaccines Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia Porcine Vaccines Revenue, (US$, Mn), 2025-2030
Table 36. By Region - Asia Porcine Vaccines Sales, (M Units), 2019-2024
Table 37. By Region - Asia Porcine Vaccines Sales, (M Units), 2025-2030
Table 38. By Country - South America Porcine Vaccines Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America Porcine Vaccines Revenue, (US$, Mn), 2025-2030
Table 40. By Country - South America Porcine Vaccines Sales, (M Units), 2019-2024
Table 41. By Country - South America Porcine Vaccines Sales, (M Units), 2025-2030
Table 42. By Country - Middle East & Africa Porcine Vaccines Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa Porcine Vaccines Revenue, (US$, Mn), 2025-2030
Table 44. By Country - Middle East & Africa Porcine Vaccines Sales, (M Units), 2019-2024
Table 45. By Country - Middle East & Africa Porcine Vaccines Sales, (M Units), 2025-2030
Table 46. Merck Company Summary
Table 47. Merck Porcine Vaccines Product Offerings
Table 48. Merck Porcine Vaccines Sales (M Units), Revenue (US$, Mn) and Average Price (USD/K Unit) (2019-2024)
Table 49. Merck Key News & Latest Developments
Table 50. Boehringer Ingelheim Company Summary
Table 51. Boehringer Ingelheim Porcine Vaccines Product Offerings
Table 52. Boehringer Ingelheim Porcine Vaccines Sales (M Units), Revenue (US$, Mn) and Average Price (USD/K Unit) (2019-2024)
Table 53. Boehringer Ingelheim Key News & Latest Developments
Table 54. Jinyu Bio-Technology Company Summary
Table 55. Jinyu Bio-Technology Porcine Vaccines Product Offerings
Table 56. Jinyu Bio-Technology Porcine Vaccines Sales (M Units), Revenue (US$, Mn) and Average Price (USD/K Unit) (2019-2024)
Table 57. Jinyu Bio-Technology Key News & Latest Developments
Table 58. CAHIC Company Summary
Table 59. CAHIC Porcine Vaccines Product Offerings
Table 60. CAHIC Porcine Vaccines Sales (M Units), Revenue (US$, Mn) and Average Price (USD/K Unit) (2019-2024)
Table 61. CAHIC Key News & Latest Developments
Table 62. Tecon Company Summary
Table 63. Tecon Porcine Vaccines Product Offerings
Table 64. Tecon Porcine Vaccines Sales (M Units), Revenue (US$, Mn) and Average Price (USD/K Unit) (2019-2024)
Table 65. Tecon Key News & Latest Developments
Table 66. Zoetis Company Summary
Table 67. Zoetis Porcine Vaccines Product Offerings
Table 68. Zoetis Porcine Vaccines Sales (M Units), Revenue (US$, Mn) and Average Price (USD/K Unit) (2019-2024)
Table 69. Zoetis Key News & Latest Developments
Table 70. Ceva Company Summary
Table 71. Ceva Porcine Vaccines Product Offerings
Table 72. Ceva Porcine Vaccines Sales (M Units), Revenue (US$, Mn) and Average Price (USD/K Unit) (2019-2024)
Table 73. Ceva Key News & Latest Developments
Table 74. Hile Bio Company Summary
Table 75. Hile Bio Porcine Vaccines Product Offerings
Table 76. Hile Bio Porcine Vaccines Sales (M Units), Revenue (US$, Mn) and Average Price (USD/K Unit) (2019-2024)
Table 77. Hile Bio Key News & Latest Developments
Table 78. Chopper Biology Company Summary
Table 79. Chopper Biology Porcine Vaccines Product Offerings
Table 80. Chopper Biology Porcine Vaccines Sales (M Units), Revenue (US$, Mn) and Average Price (USD/K Unit) (2019-2024)
Table 81. Chopper Biology Key News & Latest Developments
Table 82. WINSUN Company Summary
Table 83. WINSUN Porcine Vaccines Product Offerings
Table 84. WINSUN Porcine Vaccines Sales (M Units), Revenue (US$, Mn) and Average Price (USD/K Unit) (2019-2024)
Table 85. WINSUN Key News & Latest Developments
Table 86. Hipra Company Summary
Table 87. Hipra Porcine Vaccines Product Offerings
Table 88. Hipra Porcine Vaccines Sales (M Units), Revenue (US$, Mn) and Average Price (USD/K Unit) (2019-2024)
Table 89. Hipra Key News & Latest Developments
Table 90. Ringpu Biology Company Summary
Table 91. Ringpu Biology Porcine Vaccines Product Offerings
Table 92. Ringpu Biology Porcine Vaccines Sales (M Units), Revenue (US$, Mn) and Average Price (USD/K Unit) (2019-2024)
Table 93. Ringpu Biology Key News & Latest Developments
Table 94. DHN Company Summary
Table 95. DHN Porcine Vaccines Product Offerings
Table 96. DHN Porcine Vaccines Sales (M Units), Revenue (US$, Mn) and Average Price (USD/K Unit) (2019-2024)
Table 97. DHN Key News & Latest Developments
Table 98. CAVAC Company Summary
Table 99. CAVAC Porcine Vaccines Product Offerings
Table 100. CAVAC Porcine Vaccines Sales (M Units), Revenue (US$, Mn) and Average Price (USD/K Unit) (2019-2024)
Table 101. CAVAC Key News & Latest Developments
Table 102. Virbac Company Summary
Table 103. Virbac Porcine Vaccines Product Offerings
Table 104. Virbac Porcine Vaccines Sales (M Units), Revenue (US$, Mn) and Average Price (USD/K Unit) (2019-2024)
Table 105. Virbac Key News & Latest Developments
Table 106. HVRI Company Summary
Table 107. HVRI Porcine Vaccines Product Offerings
Table 108. HVRI Porcine Vaccines Sales (M Units), Revenue (US$, Mn) and Average Price (USD/K Unit) (2019-2024)
Table 109. HVRI Key News & Latest Developments
Table 110. Bioveta Company Summary
Table 111. Bioveta Porcine Vaccines Product Offerings
Table 112. Bioveta Porcine Vaccines Sales (M Units), Revenue (US$, Mn) and Average Price (USD/K Unit) (2019-2024)
Table 113. Bioveta Key News & Latest Developments
Table 114. Porcine Vaccines Production Capacity (M Units) of Key Manufacturers in Global Market, 2022-2024 (M Units)
Table 115. Global Porcine Vaccines Capacity Market Share of Key Manufacturers, 2022-2024
Table 116. Global Porcine Vaccines Production by Region, 2019-2024 (M Units)
Table 117. Global Porcine Vaccines Production by Region, 2025-2030 (M Units)
Table 118. Porcine Vaccines Market Opportunities & Trends in Global Market
Table 119. Porcine Vaccines Market Drivers in Global Market
Table 120. Porcine Vaccines Market Restraints in Global Market
Table 121. Porcine Vaccines Raw Materials
Table 122. Porcine Vaccines Raw Materials Suppliers in Global Market
Table 123. Typical Porcine Vaccines Downstream
Table 124. Porcine Vaccines Downstream Clients in Global Market
Table 125. Porcine Vaccines Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Porcine Vaccines Segment by Type in 2023
Figure 2. Porcine Vaccines Segment by Application in 2023
Figure 3. Global Porcine Vaccines Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Porcine Vaccines Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Porcine Vaccines Revenue, 2019-2030 (US$, Mn)
Figure 7. Porcine Vaccines Sales in Global Market: 2019-2030 (M Units)
Figure 8. The Top 3 and 5 Players Market Share by Porcine Vaccines Revenue in 2023
Figure 9. By Type - Global Porcine Vaccines Revenue, (US$, Mn), 2023 & 2030
Figure 10. By Type - Global Porcine Vaccines Revenue Market Share, 2019-2030
Figure 11. By Type - Global Porcine Vaccines Sales Market Share, 2019-2030
Figure 12. By Type - Global Porcine Vaccines Price (USD/K Unit), 2019-2030
Figure 13. By Application - Global Porcine Vaccines Revenue, (US$, Mn), 2023 & 2030
Figure 14. By Application - Global Porcine Vaccines Revenue Market Share, 2019-2030
Figure 15. By Application - Global Porcine Vaccines Sales Market Share, 2019-2030
Figure 16. By Application - Global Porcine Vaccines Price (USD/K Unit), 2019-2030
Figure 17. By Region - Global Porcine Vaccines Revenue, (US$, Mn), 2023 & 2030
Figure 18. By Region - Global Porcine Vaccines Revenue Market Share, 2019 VS 2023 VS 2030
Figure 19. By Region - Global Porcine Vaccines Revenue Market Share, 2019-2030
Figure 20. By Region - Global Porcine Vaccines Sales Market Share, 2019-2030
Figure 21. By Country - North America Porcine Vaccines Revenue Market Share, 2019-2030
Figure 22. By Country - North America Porcine Vaccines Sales Market Share, 2019-2030
Figure 23. US Porcine Vaccines Revenue, (US$, Mn), 2019-2030
Figure 24. Canada Porcine Vaccines Revenue, (US$, Mn), 2019-2030
Figure 25. Mexico Porcine Vaccines Revenue, (US$, Mn), 2019-2030
Figure 26. By Country - Europe Porcine Vaccines Revenue Market Share, 2019-2030
Figure 27. By Country - Europe Porcine Vaccines Sales Market Share, 2019-2030
Figure 28. Germany Porcine Vaccines Revenue, (US$, Mn), 2019-2030
Figure 29. France Porcine Vaccines Revenue, (US$, Mn), 2019-2030
Figure 30. U.K. Porcine Vaccines Revenue, (US$, Mn), 2019-2030
Figure 31. Italy Porcine Vaccines Revenue, (US$, Mn), 2019-2030
Figure 32. Russia Porcine Vaccines Revenue, (US$, Mn), 2019-2030
Figure 33. Nordic Countries Porcine Vaccines Revenue, (US$, Mn), 2019-2030
Figure 34. Benelux Porcine Vaccines Revenue, (US$, Mn), 2019-2030
Figure 35. By Region - Asia Porcine Vaccines Revenue Market Share, 2019-2030
Figure 36. By Region - Asia Porcine Vaccines Sales Market Share, 2019-2030
Figure 37. China Porcine Vaccines Revenue, (US$, Mn), 2019-2030
Figure 38. Japan Porcine Vaccines Revenue, (US$, Mn), 2019-2030
Figure 39. South Korea Porcine Vaccines Revenue, (US$, Mn), 2019-2030
Figure 40. Southeast Asia Porcine Vaccines Revenue, (US$, Mn), 2019-2030
Figure 41. India Porcine Vaccines Revenue, (US$, Mn), 2019-2030
Figure 42. By Country - South America Porcine Vaccines Revenue Market Share, 2019-2030
Figure 43. By Country - South America Porcine Vaccines Sales Market Share, 2019-2030
Figure 44. Brazil Porcine Vaccines Revenue, (US$, Mn), 2019-2030
Figure 45. Argentina Porcine Vaccines Revenue, (US$, Mn), 2019-2030
Figure 46. By Country - Middle East & Africa Porcine Vaccines Revenue Market Share, 2019-2030
Figure 47. By Country - Middle East & Africa Porcine Vaccines Sales Market Share, 2019-2030
Figure 48. Turkey Porcine Vaccines Revenue, (US$, Mn), 2019-2030
Figure 49. Israel Porcine Vaccines Revenue, (US$, Mn), 2019-2030
Figure 50. Saudi Arabia Porcine Vaccines Revenue, (US$, Mn), 2019-2030
Figure 51. UAE Porcine Vaccines Revenue, (US$, Mn), 2019-2030
Figure 52. Global Porcine Vaccines Production Capacity (M Units), 2019-2030
Figure 53. The Percentage of Production Porcine Vaccines by Region, 2023 VS 2030
Figure 54. Porcine Vaccines Industry Value Chain
Figure 55. Marketing Channels
